Eicosapentaenoic acid
|
Basic information |
| Metabolite name | Eicosapentaenoic acid |
 | HMDB0001999 |
 |
C06428 |
 |
446284 |
| Synonyms | Eicosapentaenoic acid |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | Eicosapentaenoic acid |
| HMDB0001999 |
|
C06428 |
|
446284 |
| Synonyms | Eicosapentaenoic acid |
| No. of studies | 10 |
|
Relationship between Eicosapentaenoic acid and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1007 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1024 | Type1 | CUMS group vs. control group | DG region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA1 region of hippocampus | ICR mouse | Down |
| Study M1024 | Type1 | CUMS group vs. control group | CA3 region of hippocampus | ICR mouse | Down |
| Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Up |
| Study M1111 | Type1 | CUMS group vs. control group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M1111 | Type1 | CUMS group vs. control group | Plasma | C57BL/6 mouse | Down |
| Study M1111 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M1111 | Type2 | CUMS + rTMS group vs. CUMS group | Prefrontal cortex | C57BL/6 mouse | Up |
| Study M1111 | Type2 | CUMS + rTMS group vs. CUMS group | Hippocampus | C57BL/6 mouse | Up |
| Study M1111 | Type2 | CUMS + rTMS group vs. CUMS group | Plasma | C57BL/6 mouse | Up |
| Study M1140 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1140 | Type2 | CUMS + Hypericum perforatum L. group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M1140 | Type2 | CUMS + Chaihu Shugan San group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Down |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Down |
| Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Down |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M600 | Type2 | high-fat diet + fish oil group vs. high-fat diet group | Forebrain | C57BL/6J mouse | Up |
| Study M784 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M784 | Type2 | CUMS + liquiritin group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M784 | Type2 | CUMS + fluoxetine group vs. CUMS group | Brain | Sprague-Dawley rat | Up |